Combined pro forma enterprise value of US$904m assumes no public trust redemptions for CCTS ...
Opus Genetics, Inc. ("Opus” or the "Company”) (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing ...
Elon Musk, CEO of SpaceX, received a summons related to an SEC lawsuit. The documents were delivered to SpaceX's Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback